Purpose: Hyposecretion of aqueous humor has been postulated to adversely affect trabecular meshwork health and outflow resistance. However, the effect of medications that reduce aqueous humor production on outflow facility in living human eyes is unclear. In this study we evaluated the effect of timolol, an aqueous humor flow suppressant, on outflow facility in healthy eyes.Design: Prospective, before-and-after study.
Methods:In a multicenter study, 113 healthy participants over age 40 years were included. Intraocular pressure (IOP) was measured in the sitting position by using a pneumatonometer and outflow facility was measured in the supine position by 2-minute pneumatonography. After one week of self-administering timolol 0.05% twice daily in each eye, both measurements were repeated.Results: Mean IOP decreased from 15.1 ± 3.0 mmHg at baseline to 12.4 ± 2.4 mmHg (P < 0.001) after one week of timolol use. Mean outflow facility decreased from 0.23 ± 0.08 μL/min/ mmHg at baseline to 0.18 ± 0.08 μL/min/mmHg (P < 0.001) after timolol. The change in outflow facility was negatively correlated with baseline outflow facility (r = −0.51, P < 0.001).
Conclusion:Timolol reduces outflow facility in healthy human eyes, and this effect is greater in eyes with higher baseline outflow facility. This phenomenon may be related to reduced aqueous humor flow, but the precise mechanism remains to be determined.